Home Page Overall Ranking ROE Ranking P/E Ranking Dividend Yield Capitalization Our eBook Our Book Contact










Isin US00287Y1091
Ticker ABBV
Company ABBVIE
Currency $
Price
Aware Investor Index (AII) 92.1729
Recommendation STRONG BUY
P/E 80.50
ROE 100.00 %
Capitalization 328,316,720,000 $
Dividend Yield 1.05 %
P/S 14.36
AII Position 41
P/E Position 707
ROE Position 29
Capitalization Position 11
Dividend Yield Position 510
Sales 22,859,000,000 $
10-Year Average Earnings 4,078,250,000 $
Shares Outstanding 1,637,000,000
Equity 3,945,000,000 $
Dividend per Share 2.1 $
Industry Pharmaceutical
Country United States
ABBVIE Investor Relations Web Site http://www.abbvieinvestor.com







Sales:

YEAR MONTH AMOUNT
2015 12 22,859,000,000.00 $
2014 12 19,960,000,000.00 $
2013 12 18,790,000,000.00 $
2012 12 18,380,000,000.00 $
2011 12 17,444,000,000.00 $
2010 12 15,638,000,000.00 $
2009 12 14,214,000,000.00 $
2008 12 14,179,000,000.00 $

Earnings:

YEAR MONTH AMOUNT
2015 12 5,144,000,000.00 $
2014 12 1,774,000,000.00 $
2013 12 4,128,000,000.00 $
2012 12 5,275,000,000.00 $
2011 12 3,433,000,000.00 $
2010 12 4,178,000,000.00 $
2009 12 4,636,000,000.00 $
2008 12 4,058,000,000.00 $

Equity:

YEAR MONTH AMOUNT
2015 12 3,945,000,000.00 $
2014 12 1,742,000,000.00 $
2013 12 4,492,000,000.00 $
2012 12 3,363,000,000.00 $

Shares Outstanding:

YEAR MONTH AMOUNT
2015 12 1,637,000,000
2014 12 1,610,000,000
2013 12 1,604,000,000
2012 12 1,577,000,000

 












Bloomberg News for ABBVIE:

Jun 12, 2013
EPS in the First Quarter of ’13 for S&P 500 Stocks by Sectors
4.8 Mar 4/23 AMGN Amgen Inc 1.96 1.61 21.7 1.84 6.5 Mar 4/26 ABBV AbbVie Inc. 0.68 0.56 21.4 0.67 1.5 Mar 5/2 ACT Actavis Inc ...
Jun 12, 2013
EPS in the First Quarter of ’13 for S&P 500 Stocks by Industry
8.6 Mar 4/23 AMGN Amgen Inc 1.96 1.61 21.7 1.84 6.5 Mar 4/26 ABBV AbbVie Inc. 0.68 0.56 21.4 0.67 1.5 Mar 5/2 ACT Actavis Inc ...
Jun 12, 2013
Positive EPS Surprises for First Quarter of ’13 for S&P 500
62 1.6 Mar 4/30 EQR Equity Residential 0.64 0.61 4.9 0.63 1.6 Mar 4/26 ABBV AbbVie Inc. 0.68 0.56 21.4 0.67 1.5 Mar 4/25 CELG Celgene Corp ...
Mar 21, 2017
Goldman Says These Dividend Stocks Will Do Well Even With the Fed Hiking Rates
WHR, HD, LOW, PHM, MO, RAI, ADM, CVS, MJN, VLO, PSX, MPC, TSO, LM, HBAN, KEY, MMC, MS, BEN, UNM, ABBV, PFE, AMGN, CAH, MDT, ABT, DGX, BA, NLSN, ITW, HON, IR, CSCO, XRX, HPQ, IBM, TXN, MSI, MSFT, GLW...
May 16, 2013
And the Winner of the Top Student-Run Investment Fund Is ...
Apache (APA), -15.42 percent UnitedHealth Group (UNH), -2.52 percent AbbVie (ABBV), -2.39 percent FIXED INCOME First Place: Stetson University...
Feb 14, 2013
SAC Capital Advisors Holdings in 4th Quarter: 13F Alert
Alcatel-Lucent-Sponsored ADR ALU US 54,244,194 39,024,600 39,024,600 AbbVie Inc ABBV US 51,877,221 1,518,654 1,518,654 Analog Devices Inc ADI US 47,426...
Dec 10, 2012
Abbott Spinoff AbbVie Begins Trading to Determine Value
percent to $30.30 at 4 p.m. New York time. AbbVie when-issued shares, trading under the ticker ABBV-W, opened at $37 and fell 5.4 percent to $35. The secondary market for the when-issued shares...
Nov 14, 2014
Maverick Capital Ltd Holdings in 3rd Quarter: 13F Alert
Plc-Series C LBTYK US 279,296,113 6,809,609 238,560 AbbVie Inc ABBV US 272,833,865 4,723,578 1,488,445 CBS Corp-Class B Non Voting CBS US 258,296...
May 3, 2013
S&P 500 Stocks Biggest Weekly Changes in Target Price
44.58 42.09 3.526 THC TENET HEALTHCAR 5.90 14 49.18 46.44 4.043 ABBV ABBVIE INC 5.85 6 46.22 43.67 3.800 TWX TIME WARNER INC 5...
Jun 12, 2013
Higher, Lower, Unchanged and Reversed EPS for S&P 500
6.7 Mar 4/23 AMGN Amgen Inc 1.96 1.61 21.7 1.84 6.5 Mar 4/26 ABBV AbbVie Inc. 0.68 0.56 21.4 0.67 1.5 Mar 4/18 AN AutoNation Inc ...


Google News for ABBVIE:

Seeking Alpha - 4 days ago
Very Cautious On AbbVie's Fundamentals
AbbVie's top line performance has been relatively strong, translating into ... Pharma companies such as AbbVie (NYSE:ABBV) and peers Merck ...
StockNewsGazette
AbbVie (ABBV) Tops Q2 Earnings and Revenue
North Chicago, IL-based AbbVie Inc. ABBV is best known for its autoimmune disease drug, Humira. AbbVie's flagship product Humira is ...
Newburgh Gazette
A Double Beat For AbbVie
AbbVie (ABBV) shows strong results with just a small number of weaknesses. The company's shares look attractive for income focused ...
BNB Daily (blog)
AbbVie's (ABBV) MAVIRET Approved by Health Canada for ...
AbbVie (NYSE: ABBV), a global biopharmaceutical company, today announced that Health Canada has granted approval for MAVIRET™ ...
Nasdaq - 28 Jul 2017
AbbVie, Part 2: Its Strengths Beyond Humira, And Weakness
Part 1 of this 2-part series briefly reviews the second quarter financial results of AbbVie (ABBV) and then engages in a detailed overview of the ...
Seeking Alpha
Lynch & Associates IN Purchases 2948 Shares of AbbVie Inc. (ABBV)
AbbVie logo Lynch & Associates IN boosted its stake in shares of AbbVie Inc. (NYSE:ABBV) by 5.0% during the second quarter, according to its ...
StreetInsider.com
13F From Farallon Capital Shows New 835K Share Stake In AbbVie
13F From Farallon Capital Shows New 835K Share Stake In AbbVie. Paul Quintaro , Benzinga Staff Writer {{following ? "Following" : "Follow"}}.
Investor's Business Daily
Evercore ISI Group Initiates Coverage On AbbVie with Outperform ...
Evercore ISI Group Initiates Coverage On AbbVie with Outperform Rating, Announces $95.00 Price Target. Paul Quintaro , Benzinga Staff ...
Seeking Alpha - 31 Jul 2017
Investors Peering into the Details on AbbVie Inc. (NYSE:ABBV)
The Current Ratio of AbbVie Inc. (NYSE:ABBV) is 1.38. The Current Ratio is used by investors to determine whether a company can pay short ...
Zacks.com
AbbVie (ABBV) & Salix Pharmaceuticals (SLXP) Critical Analysis
AbbVie (NYSE: ABBV) and Salix Pharmaceuticals (NASDAQ:SLXP) are both medical companies, but which is the better business? We will ...


Back